Prevalence of hypertension and obesity in patients with type 2 Diabetes Mellitus

Detalhes bibliográficos
Autor(a) principal: Cruz, Misma Silva
Data de Publicação: 2022
Outros Autores: da Silva, Ingrid Cristina Ferreira, Miguez, Jéssica Silva Gonçalves, Machado, Mariana Pirani Rocha
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/205464
Resumo: Faced with the increase of type 2 Diabetes mellitus (DM2) and the failure in treatment, questions have been raised about the clinical situation of these patients. The present study analyzes the prevalence of hypertension and obesity in DM2 patients. Data were collected through interviews and anamnesis of 16 participants. After the meetings, in which capillary glycemia and blood pressure were measured, the participants received guidance about glycemic monitoring, blood pressure control and changes in lifestyle. Approximately 75% of the participants were women with average age of 65 years, 87.5% were sedentary, 18.75% smoked and/or used alcoholic beverages and none performed regular blood glucose monitoring. The initial blood glucose average was 148 mg/ dL and finally decreased to 133 mg/dL. There was no significant difference in blood pressure levels. Regarding the body mass index, 89.4% of the patients were above normal standards and 100% had altered waist circumference values. There is a need for studies like this in order to promote educational practices for health and disease control, highlighting the importance of multidisciplinary teams and the pharmaceutical professional, since non-adherence to blood glucose monitoring, also associated with hypertension and obesity, can interfere with the individual’s clinical condition.
id USP-31_6e7e2ae95deed805442302d43759d836
oai_identifier_str oai:revistas.usp.br:article/205464
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Prevalence of hypertension and obesity in patients with type 2 Diabetes MellitusChronic noncommunicable diseaseHyperglycemiaHypertensiveOverweightEducational practicesFaced with the increase of type 2 Diabetes mellitus (DM2) and the failure in treatment, questions have been raised about the clinical situation of these patients. The present study analyzes the prevalence of hypertension and obesity in DM2 patients. Data were collected through interviews and anamnesis of 16 participants. After the meetings, in which capillary glycemia and blood pressure were measured, the participants received guidance about glycemic monitoring, blood pressure control and changes in lifestyle. Approximately 75% of the participants were women with average age of 65 years, 87.5% were sedentary, 18.75% smoked and/or used alcoholic beverages and none performed regular blood glucose monitoring. The initial blood glucose average was 148 mg/ dL and finally decreased to 133 mg/dL. There was no significant difference in blood pressure levels. Regarding the body mass index, 89.4% of the patients were above normal standards and 100% had altered waist circumference values. There is a need for studies like this in order to promote educational practices for health and disease control, highlighting the importance of multidisciplinary teams and the pharmaceutical professional, since non-adherence to blood glucose monitoring, also associated with hypertension and obesity, can interfere with the individual’s clinical condition.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2022-12-23info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/20546410.1590/s2175-97902022e20497Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/205464/197244Copyright (c) 2022 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessCruz, Misma Silvada Silva, Ingrid Cristina FerreiraMiguez, Jéssica Silva Gonçalves Machado, Mariana Pirani Rocha2023-08-23T14:10:12Zoai:revistas.usp.br:article/205464Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-08-23T14:10:12Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Prevalence of hypertension and obesity in patients with type 2 Diabetes Mellitus
title Prevalence of hypertension and obesity in patients with type 2 Diabetes Mellitus
spellingShingle Prevalence of hypertension and obesity in patients with type 2 Diabetes Mellitus
Cruz, Misma Silva
Chronic noncommunicable disease
Hyperglycemia
Hypertensive
Overweight
Educational practices
title_short Prevalence of hypertension and obesity in patients with type 2 Diabetes Mellitus
title_full Prevalence of hypertension and obesity in patients with type 2 Diabetes Mellitus
title_fullStr Prevalence of hypertension and obesity in patients with type 2 Diabetes Mellitus
title_full_unstemmed Prevalence of hypertension and obesity in patients with type 2 Diabetes Mellitus
title_sort Prevalence of hypertension and obesity in patients with type 2 Diabetes Mellitus
author Cruz, Misma Silva
author_facet Cruz, Misma Silva
da Silva, Ingrid Cristina Ferreira
Miguez, Jéssica Silva Gonçalves
Machado, Mariana Pirani Rocha
author_role author
author2 da Silva, Ingrid Cristina Ferreira
Miguez, Jéssica Silva Gonçalves
Machado, Mariana Pirani Rocha
author2_role author
author
author
dc.contributor.author.fl_str_mv Cruz, Misma Silva
da Silva, Ingrid Cristina Ferreira
Miguez, Jéssica Silva Gonçalves
Machado, Mariana Pirani Rocha
dc.subject.por.fl_str_mv Chronic noncommunicable disease
Hyperglycemia
Hypertensive
Overweight
Educational practices
topic Chronic noncommunicable disease
Hyperglycemia
Hypertensive
Overweight
Educational practices
description Faced with the increase of type 2 Diabetes mellitus (DM2) and the failure in treatment, questions have been raised about the clinical situation of these patients. The present study analyzes the prevalence of hypertension and obesity in DM2 patients. Data were collected through interviews and anamnesis of 16 participants. After the meetings, in which capillary glycemia and blood pressure were measured, the participants received guidance about glycemic monitoring, blood pressure control and changes in lifestyle. Approximately 75% of the participants were women with average age of 65 years, 87.5% were sedentary, 18.75% smoked and/or used alcoholic beverages and none performed regular blood glucose monitoring. The initial blood glucose average was 148 mg/ dL and finally decreased to 133 mg/dL. There was no significant difference in blood pressure levels. Regarding the body mass index, 89.4% of the patients were above normal standards and 100% had altered waist circumference values. There is a need for studies like this in order to promote educational practices for health and disease control, highlighting the importance of multidisciplinary teams and the pharmaceutical professional, since non-adherence to blood glucose monitoring, also associated with hypertension and obesity, can interfere with the individual’s clinical condition.
publishDate 2022
dc.date.none.fl_str_mv 2022-12-23
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/205464
10.1590/s2175-97902022e20497
url https://www.revistas.usp.br/bjps/article/view/205464
identifier_str_mv 10.1590/s2175-97902022e20497
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/205464/197244
dc.rights.driver.fl_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)
Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)
Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222916620582912